Cargando…
International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and professional organization founded in 1954 to promote the science, technology, and practical application of nuclear medicine. The European Association of Nuclear Medicine (EANM) is a professional non-prof...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547645/ https://www.ncbi.nlm.nih.gov/pubmed/37624384 http://dx.doi.org/10.1007/s00259-023-06406-x |
_version_ | 1785115097775996928 |
---|---|
author | Veit-Haibach, Patrick Ahlström, Håkan Boellaard, Ronald Delgado Bolton, Roberto C. Hesse, Swen Hope, Thomas Huellner, Martin W. Iagaru, Andrei Johnson, Geoffrey B. Kjaer, Andreas Law, Ian Metser, Ur Quick, Harald H. Sattler, Bernhard Umutlu, Lale Zaharchuk, Greg Herrmann, Ken |
author_facet | Veit-Haibach, Patrick Ahlström, Håkan Boellaard, Ronald Delgado Bolton, Roberto C. Hesse, Swen Hope, Thomas Huellner, Martin W. Iagaru, Andrei Johnson, Geoffrey B. Kjaer, Andreas Law, Ian Metser, Ur Quick, Harald H. Sattler, Bernhard Umutlu, Lale Zaharchuk, Greg Herrmann, Ken |
author_sort | Veit-Haibach, Patrick |
collection | PubMed |
description | The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and professional organization founded in 1954 to promote the science, technology, and practical application of nuclear medicine. The European Association of Nuclear Medicine (EANM) is a professional non-profit medical association that facilitates communication worldwide between individuals pursuing clinical and research excellence in nuclear medicine. The EANM was founded in 1985. The merged International Society for Magnetic Resonance in Medicine (ISMRM) is an international, nonprofit, scientific association whose purpose is to promote communication, research, development, and applications in the field of magnetic resonance in medicine and biology and other related topics and to develop and provide channels and facilities for continuing education in the field.The ISMRM was founded in 1994 through the merger of the Society of Magnetic Resonance in Medicine and the Society of Magnetic Resonance Imaging. SNMMI, ISMRM, and EANM members are physicians, technologists, and scientists specializing in the research and practice of nuclear medicine and/or magnetic resonance imaging. The SNMMI, ISMRM, and EANM will periodically define new guidelines for nuclear medicine practice to help advance the science of nuclear medicine and/or magnetic resonance imaging and to improve the quality of service to patients throughout the world. Existing practice guidelines will be reviewed for revision or renewal, as appropriate, on their fifth anniversary or sooner, if indicated. Each practice guideline, representing a policy statement by the SNMMI/EANM/ISMRM, has undergone a thorough consensus process in which it has been subjected to extensive review. The SNMMI, ISMRM, and EANM recognize that the safe and effective use of diagnostic nuclear medicine imaging and magnetic resonance imaging requires specific training, skills, and techniques, as described in each document. Reproduction or modification of the published practice guideline by those entities not providing these services is not authorized. These guidelines are an educational tool designed to assist practitioners in providing appropriate care for patients. They are not inflexible rules or requirements of practice and are not intended, nor should they be used, to establish a legal standard of care. For these reasons and those set forth below, the SNMMI, the ISMRM, and the EANM caution against the use of these guidelines in litigation in which the clinical decisions of a practitioner are called into question. The ultimate judgment regarding the propriety of any specific procedure or course of action must be made by the physician or medical physicist in light of all the circumstances presented. Thus, there is no implication that an approach differing from the guidelines, standing alone, is below the standard of care. To the contrary, a conscientious practitioner may responsibly adopt a course of action different from that set forth in the guidelines when, in the reasonable judgment of the practitioner, such course of action is indicated by the condition of the patient, limitations of available resources, or advances in knowledge or technology subsequent to publication of the guidelines. The practice of medicine includes both the art and the science of the prevention, diagnosis, alleviation, and treatment of disease. The variety and complexity of human conditions make it impossible to always reach the most appropriate diagnosis or to predict with certainty a particular response to treatment. Therefore, it should be recognized that adherence to these guidelines will not ensure an accurate diagnosis or a successful outcome. All that should be expected is that the practitioner will follow a reasonable course of action based on current knowledge, available resources, and the needs of the patient to deliver effective and safe medical care. The sole purpose of these guidelines is to assist practitioners in achieving this objective. |
format | Online Article Text |
id | pubmed-10547645 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-105476452023-10-05 International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology Veit-Haibach, Patrick Ahlström, Håkan Boellaard, Ronald Delgado Bolton, Roberto C. Hesse, Swen Hope, Thomas Huellner, Martin W. Iagaru, Andrei Johnson, Geoffrey B. Kjaer, Andreas Law, Ian Metser, Ur Quick, Harald H. Sattler, Bernhard Umutlu, Lale Zaharchuk, Greg Herrmann, Ken Eur J Nucl Med Mol Imaging Guidelines The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and professional organization founded in 1954 to promote the science, technology, and practical application of nuclear medicine. The European Association of Nuclear Medicine (EANM) is a professional non-profit medical association that facilitates communication worldwide between individuals pursuing clinical and research excellence in nuclear medicine. The EANM was founded in 1985. The merged International Society for Magnetic Resonance in Medicine (ISMRM) is an international, nonprofit, scientific association whose purpose is to promote communication, research, development, and applications in the field of magnetic resonance in medicine and biology and other related topics and to develop and provide channels and facilities for continuing education in the field.The ISMRM was founded in 1994 through the merger of the Society of Magnetic Resonance in Medicine and the Society of Magnetic Resonance Imaging. SNMMI, ISMRM, and EANM members are physicians, technologists, and scientists specializing in the research and practice of nuclear medicine and/or magnetic resonance imaging. The SNMMI, ISMRM, and EANM will periodically define new guidelines for nuclear medicine practice to help advance the science of nuclear medicine and/or magnetic resonance imaging and to improve the quality of service to patients throughout the world. Existing practice guidelines will be reviewed for revision or renewal, as appropriate, on their fifth anniversary or sooner, if indicated. Each practice guideline, representing a policy statement by the SNMMI/EANM/ISMRM, has undergone a thorough consensus process in which it has been subjected to extensive review. The SNMMI, ISMRM, and EANM recognize that the safe and effective use of diagnostic nuclear medicine imaging and magnetic resonance imaging requires specific training, skills, and techniques, as described in each document. Reproduction or modification of the published practice guideline by those entities not providing these services is not authorized. These guidelines are an educational tool designed to assist practitioners in providing appropriate care for patients. They are not inflexible rules or requirements of practice and are not intended, nor should they be used, to establish a legal standard of care. For these reasons and those set forth below, the SNMMI, the ISMRM, and the EANM caution against the use of these guidelines in litigation in which the clinical decisions of a practitioner are called into question. The ultimate judgment regarding the propriety of any specific procedure or course of action must be made by the physician or medical physicist in light of all the circumstances presented. Thus, there is no implication that an approach differing from the guidelines, standing alone, is below the standard of care. To the contrary, a conscientious practitioner may responsibly adopt a course of action different from that set forth in the guidelines when, in the reasonable judgment of the practitioner, such course of action is indicated by the condition of the patient, limitations of available resources, or advances in knowledge or technology subsequent to publication of the guidelines. The practice of medicine includes both the art and the science of the prevention, diagnosis, alleviation, and treatment of disease. The variety and complexity of human conditions make it impossible to always reach the most appropriate diagnosis or to predict with certainty a particular response to treatment. Therefore, it should be recognized that adherence to these guidelines will not ensure an accurate diagnosis or a successful outcome. All that should be expected is that the practitioner will follow a reasonable course of action based on current knowledge, available resources, and the needs of the patient to deliver effective and safe medical care. The sole purpose of these guidelines is to assist practitioners in achieving this objective. Springer Berlin Heidelberg 2023-08-25 2023 /pmc/articles/PMC10547645/ /pubmed/37624384 http://dx.doi.org/10.1007/s00259-023-06406-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Guidelines Veit-Haibach, Patrick Ahlström, Håkan Boellaard, Ronald Delgado Bolton, Roberto C. Hesse, Swen Hope, Thomas Huellner, Martin W. Iagaru, Andrei Johnson, Geoffrey B. Kjaer, Andreas Law, Ian Metser, Ur Quick, Harald H. Sattler, Bernhard Umutlu, Lale Zaharchuk, Greg Herrmann, Ken International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology |
title | International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology |
title_full | International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology |
title_fullStr | International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology |
title_full_unstemmed | International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology |
title_short | International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology |
title_sort | international eanm-snmmi-ismrm consensus recommendation for pet/mri in oncology |
topic | Guidelines |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547645/ https://www.ncbi.nlm.nih.gov/pubmed/37624384 http://dx.doi.org/10.1007/s00259-023-06406-x |
work_keys_str_mv | AT veithaibachpatrick internationaleanmsnmmiismrmconsensusrecommendationforpetmriinoncology AT ahlstromhakan internationaleanmsnmmiismrmconsensusrecommendationforpetmriinoncology AT boellaardronald internationaleanmsnmmiismrmconsensusrecommendationforpetmriinoncology AT delgadoboltonrobertoc internationaleanmsnmmiismrmconsensusrecommendationforpetmriinoncology AT hesseswen internationaleanmsnmmiismrmconsensusrecommendationforpetmriinoncology AT hopethomas internationaleanmsnmmiismrmconsensusrecommendationforpetmriinoncology AT huellnermartinw internationaleanmsnmmiismrmconsensusrecommendationforpetmriinoncology AT iagaruandrei internationaleanmsnmmiismrmconsensusrecommendationforpetmriinoncology AT johnsongeoffreyb internationaleanmsnmmiismrmconsensusrecommendationforpetmriinoncology AT kjaerandreas internationaleanmsnmmiismrmconsensusrecommendationforpetmriinoncology AT lawian internationaleanmsnmmiismrmconsensusrecommendationforpetmriinoncology AT metserur internationaleanmsnmmiismrmconsensusrecommendationforpetmriinoncology AT quickharaldh internationaleanmsnmmiismrmconsensusrecommendationforpetmriinoncology AT sattlerbernhard internationaleanmsnmmiismrmconsensusrecommendationforpetmriinoncology AT umutlulale internationaleanmsnmmiismrmconsensusrecommendationforpetmriinoncology AT zaharchukgreg internationaleanmsnmmiismrmconsensusrecommendationforpetmriinoncology AT herrmannken internationaleanmsnmmiismrmconsensusrecommendationforpetmriinoncology |